The use of functional epirubicin liposomes to induce programmed death in refractory breast cancer
Lei Liu, Li-Min Mu, Yan Yan, Jia-Shuan Wu, Ying-Jie Hu, Ying-Zi Bu, Jing-Ying Zhang, Rui Liu, Xue-Qi Li, Wan-Liang Lu Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Be...
Main Authors: | Liu L, Mu LM, Yan Y, Wu JS, Hu YJ, Bu YZ, Zhang JY, Liu R, Li XQ, Lu WL |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-06-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/the-use-of-functional-epirubicin-liposomes-to-induce-programmed-death--peer-reviewed-article-IJN |
Similar Items
-
Efficacy and safety of pegylated liposomal doxorubicin and epirubicin as neoadjuvant chemotherapy for breast cancer
by: Yuanyuan Shen, et al.
Published: (2024-12-01) -
Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma
by: Ju RJ, et al.
Published: (2016-03-01) -
Pegylated Liposomal Doxorubicin Versus Epirubicin as Adjuvant Therapy for Stage I–III Breast Cancer
by: Wenxian Hu, et al.
Published: (2021-09-01) -
Efficacy of Acetazolamide in Refractory Epilepsy Management: A Quasi-Experimental Study
by: Muhammad Ahmed Zamir, et al.
Published: (2023-06-01) -
Voltage-dependent anion channels mediated apoptosis in refractory epilepsy
by: Zhao Yan, et al.
Published: (2020-08-01)